0000950170-24-056082.txt : 20240508
0000950170-24-056082.hdr.sgml : 20240508
20240508191846
ACCESSION NUMBER: 0000950170-24-056082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DelAversano Robert J
CENTRAL INDEX KEY: 0001728262
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35776
FILM NUMBER: 24928014
MAIL ADDRESS:
STREET 1: 217 W. MAIN STREET
CITY: SOMERVILLE
STATE: NJ
ZIP: 08876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acasti Pharma Inc.
CENTRAL INDEX KEY: 0001444192
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-649-9272
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER
STREET 2: SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
ownership.xml
4
X0508
4
2024-05-06
0001444192
Acasti Pharma Inc.
ACST
0001728262
DelAversano Robert J
103 CARNEGIE CENTER
SUITE 300
PRINCETON
NJ
08540
false
true
false
false
Principal Financial Officer
false
Stock Options (Right to Buy)
2.96
2024-05-06
4
A
false
4500
0
A
2034-05-06
Class A Common Shares
4500
4500
D
Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period.
/s/ Robert J. DelAversano
2024-05-08